TABLE OF CONTENTS

1. INTRODUCTION 19
1.1. OBJECTIVES OF THE STUDY 19
1.2. MARKET DEFINITION 19
1.3. OVERVIEW OF ASIA-PACIFIC CHOLESTEROL TESTING MARKET 19
1.4. CURRENCY AND PRICING 20
1.5. LIMITATION 20
1.6. MARKETS COVERED 21
2. MARKET SEGMENTATION 23
2.1. MARKETS COVERED 23
2.2. GEOGRAPHIC SCOPE 24
2.3. YEARS CONSIDERED FOR THE STUDY 25
2.4. CURRENCY AND PRICING 25
2.5. RESEARCH METHODOLOGY 26
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 29
2.7. SECONDARY SOURCES 30
2.8. ASSUMPTIONS 30
3. EXECUTIVE SUMMARY 31
4. MARKET OVERVIEW 34
4.1. DRIVERS 36
4.2. RESTRAINTS 38
4.3. OPPORTUNITIES 39
4.4. CHALLENGES 40
5. PREMIUM INSIGHTS 41
6. ASIA-PACIFIC CHOLESTEROL TESTING MARKET, BY PRODUCT TYPE 42
6.1. OVERVIEW 43
6.2. TESTING STRIPS 45
6.3. TEST KITS 46
7. ASIA-PACIFIC CHOLESTEROL TESTING MARKET, BY TEST 47
7.1. OVERVIEW 48
7.2. LIPID PANEL TEST/COMPLETE LIPID PROFILE 50
7.2.1. TOTAL CHOLESTEROL TEST 51
7.2.2. HDL CHOLESTEROL TEST 51
7.2.3. LDL CHOLESTEROL TEST 52
7.2.4. TRIGLYCERIDES/VLDL CHOLESTEROL TEST 52
7.3. APOLIPOPROTEIN B TEST 53
7.4. APOLIPOPROTEIN A-1 TEST 54
7.5. APOE GENOTYPING TEST 55
7.6. APOLIPOPROTEIN CII 56
7.7. OTHERS 57
8. ASIA-PACIFIC CHOLESTEROL TESTING MARKET, BY TEST TYPE 58
8.1. OVERVIEW 59
8.2. NON-INVASIVE 61
8.3. INVASIVE 62
9. ASIA-PACIFIC CHOLESTEROL TESTING MARKET, BY PRESCRIPTION MODE 63
9.1. OVERVIEW 64
9.2. OVER THE COUNTER 66
9.3. PRESCRIPTION BASED 67
10. ASIA-PACIFIC CHOLESTEROL TESTING MARKET, BY END-USERS 68
10.1. OVERVIEW 69
10.2. CLINICS 71
10.3. HOSPITALS 72
10.4. AMBULATORY CENTERS 73
10.5. HOMECARE 74
10.6. DIAGNOSTIC CENTERS 75
10.7. ASIA-PACIFIC 76
10.7.1. JAPAN 86
10.7.2. CHINA 89
10.7.3. INDIA 92
10.7.4. SOUTH KOREA 95
10.7.5. AUSTRALIA 98
10.7.6. SINGAPORE 101
10.7.7. THAILAND 104
10.7.8. MALAYSIA 107
10.7.9. INDONESIA 110
10.7.10. PHILIPPINES 113
10.7.11. REST OF ASIA-PACIFIC 116
11. ASIA-PACIFIC CHOLESTEROL TESTING MARKET, COMPANY LANDSCAPE 118
11.1. COMPANY SHARE ANALYSIS; ASIA-PACIFIC 118
12. COMPANY PROFILES 119
12.1. BIO-RAD LABORATORIES, INC. 119
12.1.1. COMPANY OVERVIEW 119
12.1.2. BIO-RAD LABORATORIES, INC.; REVENUE ANALYSIS 119
12.1.3. PRODUCT PORTFOLIO 120
12.1.4. RECENT DEVELOPMENTS 120
12.2. ABBOTT 121
12.2.1. COMPANY OVERVIEW 121
12.2.2. ABBOTT; REVENUE ANALYSIS 121
12.2.3. PRODUCT PORTFOLIO 122
12.2.4. RECENT DEVELOPMENTS 122
12.3. SIEMENS AG 123
12.3.1. COMPANY OVERVIEW 123
12.3.2. SIEMENS AG; REVENUE ANALYSIS 123
12.3.3. PRODUCT PORTFOLIO 124
12.3.4. RECENT DEVELOPMENTS 124
12.4. ALERE INC. 125
12.4.1. COMPANY OVERVIEW 125
12.4.2. ALERE INC.; REVENUE ANALYSIS 125
12.4.3. PRODUCT PORTFOLIO 126
12.4.4. RECENT DEVELOPMENTS 126
12.5. SIGMA ALDRICH (A SUBSIDIARY OF MERCK KGAA) 127
12.5.1. COMPANY OVERVIEW 127
12.5.2. MERCK KGAA; REVENUE ANALYSIS 127
12.5.3. PRODUCT PORTFOLIO 128
12.5.4. RECENT DEVELOPMENTS 128
12.6. F. HOFFMANN-LA ROCHE LTD 129
12.6.1. COMPANY OVERVIEW 129
12.6.2. F. HOFFMANN-LA ROCHE LTD;REVENUE ANALYSIS 129
12.6.3. PRODUCT PORTFOLIO 130
12.6.4. RECENT DEVELOPMENTS 130
12.7. DANAHER 131
12.7.1. COMPANY OVERVIEW 131
12.7.2. DANAHER; REVENUE ANALYSIS 131
12.7.3. PRODUCT PORTFOLIO 132
12.7.4. RECENT DEVELOPMENTS 132
12.8. QUEST DIAGNOSTICS INCORPORATED 133
12.8.1. COMPANY OVERVIEW 133
12.8.2. QUEST DIAGNOSTICS INCORPORATED; REVENUE ANALYSIS 133
12.8.3. PRODUCT PORTFOLIO 134
12.8.4. RECENT DEVELOPMENTS 134
12.9. ACCUTECH, LLC 135
12.9.1. COMPANY OVERVIEW 135
12.9.2. ACCUTECH, LLC; COMPANY SNAPSHOT 135
12.9.3. PRODUCT PORTFOLIO 135
12.9.4. RECENT DEVELOPMENTS 135
12.10. PRIMA LAB SA 136
12.10.1. COMPANY OVERVIEW 136
12.10.2. PRIMA LAB SA; COMPANY SNAPSHOT 136
12.10.3. PRODUCT PORTFOLIO 136
12.10.4. RECENT DEVELOPMENTS 136
12.11. HOME ACCESS HEALTH CORPORATION 137
12.11.1. COMPANY OVERVIEW 137
12.11.2. HOME ACCESS HEALTH CORPORATION; COMPANY SNAPSHOT 137
12.11.3. PRODUCT PORTFOLIO 137
12.11.4. RECENT DEVELOPMENTS 137
12.12. EUROFINS SCIENTIFIC 138
12.12.1. COMPANY OVERVIEW 138
12.12.2. EUROFINS SCIENTIFIC; REVENUE ANALYSIS 138
12.12.3. PRODUCT PORTFOLIO 139
12.12.4. RECENT DEVELOPMENTS 139
12.13. RANDOX LABORATORIES LTD. 140
12.13.1. COMPANY OVERVIEW 140
12.13.2. RANDOX LABORATORIES LTD.; COMPANY SNAPSHOT 140
12.13.3. PRODUCT PORTFOLIO 140
12.13.4. RECENT DEVELOPMENTS 140
12.14. PTS DIAGNOSTICS 141
12.14.1. COMPANY OVERVIEW 141
12.14.2. PTS DIAGNOSTIC; COMPANY SNAPSHOT 141
12.14.3. PRODUCT PORTFOLIO 142
12.14.4. RECENT DEVELOPMENTS 142
13. RELATED REPORTS 143